This inventor holds 2 USPTO granted patents. Top assignees: Cellular Biomedicine Group (Shanghai) Ltd., Cellular Biomedicine Group (Wuxi) Ltd., Shanghai Cellular Biopharmaceutical Group Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 4 
1 out of 2 Years Active: 2026
Title: Yutian Wei: Innovator in Biopharmaceuticals
Introduction
Yutian Wei is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies.
Latest Patents
Yutian Wei holds a patent for "Anti-BCMA Antibodies and Chimeric Antigen Receptors." This patent represents a crucial advancement in targeted therapies for certain types of cancers.
Career Highlights
Wei is currently associated with Shanghai Cellular Biopharmaceutical Group Ltd., where he applies his expertise in biopharmaceutical research and development. His work focuses on creating effective treatments that can improve patient outcomes.
Collaborations
Yutian Wei collaborates with notable colleagues, including Jiaqi Huang and Yihong Yao, to drive innovation in their projects.
Conclusion
Yutian Wei's contributions to biopharmaceuticals, particularly through his patent and collaborative efforts, highlight his role as a key innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile